[HTML][HTML] Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?

P Pais, V Almeida, M Yılmaz, MC Teixeira - Journal of Fungi, 2020 - mdpi.com
Saccharomyces boulardii is a probiotic yeast often used for the treatment of GI tract
disorders such as diarrhea symptoms. It is genetically close to the model yeast …

[HTML][HTML] Recent progress in nanomaterial-based sensing of airborne viral and bacterial pathogens

SK Bhardwaj, N Bhardwaj, V Kumar, D Bhatt… - Environment …, 2021 - Elsevier
Airborne pathogens are small microbes that can cause a multitude of diseases (eg, the
common cold, flu, asthma, anthrax, tuberculosis, botulism, and pneumonia). As pathogens …

Structure and function of the EA1 surface layer of Bacillus anthracis

A Sogues, A Fioravanti, W Jonckheere… - Nature …, 2023 - nature.com
The Gram-positive spore-forming bacterium Bacillus anthracis is the causative agent of
anthrax, a deadly disease mostly affecting wildlife and livestock, as well as representing a …

[KÖNYV][B] Nelson's pediatric antimicrobial therapy

JS Bradley - 2012 - publications.aap.org
Welcome to the 30th edition of Nelson's Pediatric Antimicrobial Therapy! The infectious
disease (ID) landscape has certainly continued to change over the past year, with COVID-19 …

Nanobodies: The potential application in bacterial treatment and diagnosis

S Yu, L Zhang, A Wang, Y **, D Zhou - Biochemical Pharmacology, 2023 - Elsevier
An infection caused by bacteria is one of the main factors that poses a threat to human
health. A recent report from the World Health Organization (WHO) has highlighted that …

An overview of anthrax infection including the recently identified form of disease in injection drug users

CW Hicks, DA Sweeney, X Cui, Y Li… - Intensive care medicine, 2012 - Springer
Purpose Bacillus anthracis infection (anthrax) can be highly lethal. Two recent outbreaks
related to contaminated mail in the USA and heroin in the UK and Europe and its potential …

Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms

MK Dassanayake, TJ Khoo, J An - Annals of clinical microbiology and …, 2021 - Springer
Background and objectives The chemotherapeutic management of infections has become
challenging due to the global emergence of antibiotic resistant pathogenic bacteria. The …

[HTML][HTML] Prophylactic vaccine delivery systems against epidemic infectious diseases

C Pan, H Yue, L Zhu, G Ma, H Wang - Advanced drug delivery reviews, 2021 - Elsevier
Prophylactic vaccines have evolved from traditional whole-cell vaccines to safer subunit
vaccines. However, subunit vaccines still face problems, such as poor immunogenicity and …

Biosensors for monitoring airborne pathogens

CF Fronczek, JY Yoon - Journal of laboratory automation, 2015 - journals.sagepub.com
Airborne pathogens affect both humans and animals and are often highly and rapidly
transmittable. Many problematic airborne pathogens, both viral (influenza A/H1N1, Rubella …

Raxibacumab: potential role in the treatment of inhalational anthrax

CE Kummerfeldt - Infection and drug resistance, 2014 - Taylor & Francis
Anthrax is a highly contagious and potentially fatal human disease caused by Bacillus
anthracis, an aerobic, Gram-positive, spore-forming rod-shaped bacterium with worldwide …